What is Alumis Inc (ALMS) stock price today?

Alumis Inc (ALMS) currently trades at $24.69 per share. The stock has a market capitalization of $3.17B and a P/E ratio of —x.

Is ALMS stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Alumis Inc has a Smart Value Score of 24/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 6/9 and Altman Z-Score is -3.94.

What is Alumis Inc's revenue and earnings?

Alumis Inc has trailing twelve-month (TTM) revenue of $24.05M with profit margins of 0.00%. Earnings per share (EPS) is $-2.86.

Is Alumis Inc financially healthy?

Alumis Inc's Piotroski F-Score is 6/9 (moderate financial health). The Altman Z-Score of -3.94 places it in the distress.

ALMS

Alumis Inc

NASDAQ: ALMS · HEALTHCARE · BIOTECHNOLOGY

$24.69

+7.86% today

Updated 2026-04-30

Market cap

$3.17B

P/E ratio

—

P/S ratio

131.85x

EPS (TTM)

$-2.86

Dividend yield

—

52W range

$3 – $31

Volume

1.5M

Market cap

$3.17B

P/E ratio

—

P/S ratio

131.85x

EPS (TTM)

$-2.86

Dividend yield

—

52W range

$3 – $31

Volume

1.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

7.5

Quality

B+

2.5

Profitability

5.0

Valuation

C+

6/9

Piotroski F-Score

Moderate

-3.9

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$38.40

+55.53%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy10 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.10x — low leverage

Risks

- Altman Z -3.94 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-71.91M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$24.05M	$24.05M
Net income	$-111.93M	$-154.99M	$-294.23M	$-243.32M	$-92.93M
EPS	—	—	—	—	$-2.86
Free cash flow	$-110.13M	$-134.47M	$-256.81M	$-370.18M	$-71.91M
Profit margin	—	—	—	-1,011.75%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ALMS	$3.17B	24	4.3	2.5	5.0	7.5	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Alumis Inc trades at $24.69. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 6/9 on the Piotroski F-Score. With an Altman Z-Score of -3.94, it sits in the distress. TTM revenue stands at $24.05M.

Frequently asked questions

What is Alumis Inc's stock price?

Alumis Inc (ALMS) trades at $24.69.

Is Alumis Inc overvalued?

Smart Value Score 24/100 (Grade F, Strong Sell).

What is the price target of Alumis Inc (ALMS)?

The analyst target price is $38.40, representing +55.5% upside from the current price of $24.69.

What is Alumis Inc's revenue?

TTM revenue is $24.05M.

Piotroski F-Score?

6/9 — moderate financial health.

Altman Z-Score?

-3.94 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.alumis.com

Quick metrics

P/S ratio131.85x

ROE-86.70%

Beta—

50D MA$25.60

200D MA$13.10

Shares out0.12B

Float0.08B

Short ratio—

Avg volume1.5M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ALMS vs LLY →ALMS vs JNJ →ALMS vs ABBV →Stock screener →